Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer.

Asgharzadeh, Fereshteh; Geraylow, Kiarash Roustai; Khazaei, Majid; Nassiri, Mohammadreza; Hassanian, Seyed Mahdi; Ferns, Gordon A; Avan, Amir

Asgharzadeh, Fereshteh; Geraylow, Kiarash Roustai; Khazaei, Majid; Nassiri, Mohammadreza; Hassanian, Seyed Mahdi; Ferns, Gordon A; Avan, Amir.

Afiliación

Asgharzadeh F; Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Geraylow KR; Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran.
Khazaei M; Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Nassiri M; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Hassanian SM; Recombinant Proteins Research Group, The Research Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
Ferns GA; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Avan A; Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Curr Cancer Drug Targets ; 22(10): 785-795, 2022.

Article en En | MEDLINE | ID: mdl-35585824

Asunto(s)

Enfermedades Cardiovasculares; Neoplasias Pancreáticas; Angiotensina II/uso terapéutico; Antagonistas de Receptores de Angiotensina/uso terapéutico; Inhibidores de la Enzima Convertidora de Angiotensina/farmacología; Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico; Enfermedades Cardiovasculares/tratamiento farmacológico; Humanos; Neoplasias Pancreáticas/tratamiento farmacológico; Estudios Prospectivos; Neoplasias Pancreáticas

Palabras clave

ACE inhibitors; ARB inhibitors; Pancreatic cancer; carcinogenesis; gemcitabine; renin-angiotensin system

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Enfermedades Cardiovasculares Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Cancer Drug Targets Asunto de la revista: ANTINEOPLASICOS / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google